213 related articles for article (PubMed ID: 35008264)
1. Nelfinavir Induces Cytotoxicity towards High-Grade Serous Ovarian Cancer Cells, Involving Induction of the Unfolded Protein Response, Modulation of Protein Synthesis, DNA Damage, Lysosomal Impairment, and Potentiation of Toxicity Caused by Proteasome Inhibition.
Subeha MR; Goyeneche AA; Bustamante P; Lisio MA; Burnier JV; Telleria CM
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008264
[TBL] [Abstract][Full Text] [Related]
2. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells.
Chakravarty G; Mathur A; Mallade P; Gerlach S; Willis J; Datta A; Srivastav S; Abdel-Mageed AB; Mondal D
Biochimie; 2016 May; 124():53-64. PubMed ID: 26844637
[TBL] [Abstract][Full Text] [Related]
3. The HIV protease inhibitor nelfinavir down-regulates RET signaling and induces apoptosis in medullary thyroid cancer cells.
Kushchayeva Y; Jensen K; Recupero A; Costello J; Patel A; Klubo-Gwiezdzinska J; Boyle L; Burman K; Vasko V
J Clin Endocrinol Metab; 2014 May; 99(5):E734-45. PubMed ID: 24483157
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology Based Repositioning of an Anti-Viral Drug for Non-Small Cell Lung Cancer (NSCLC).
Parvathaneni V; Goyal M; Kulkarni NS; Shukla SK; Gupta V
Pharm Res; 2020 Jun; 37(7):123. PubMed ID: 32514688
[TBL] [Abstract][Full Text] [Related]
5. Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells.
Abdalbari FH; Martinez-Jaramillo E; Forgie BN; Tran E; Zorychta E; Goyeneche AA; Sabri S; Telleria CM
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958311
[TBL] [Abstract][Full Text] [Related]
6. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
[TBL] [Abstract][Full Text] [Related]
7. Nelfinavir inhibits proliferation and induces DNA damage in thyroid cancer cells.
Jensen K; Bikas A; Patel A; Kushchayeva Y; Costello J; McDaniel D; Burman K; Vasko V
Endocr Relat Cancer; 2017 Mar; 24(3):147-156. PubMed ID: 28137980
[TBL] [Abstract][Full Text] [Related]
8. Nelfinavir induces liposarcoma apoptosis through inhibition of regulated intramembrane proteolysis of SREBP-1 and ATF6.
Guan M; Fousek K; Jiang C; Guo S; Synold T; Xi B; Shih CC; Chow WA
Clin Cancer Res; 2011 Apr; 17(7):1796-806. PubMed ID: 21355074
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of nelfinavir and bortezomib on proteotoxic death of NSCLC and multiple myeloma cells.
Kawabata S; Gills JJ; Mercado-Matos JR; Lopiccolo J; Wilson W; Hollander MC; Dennis PA
Cell Death Dis; 2012 Jul; 3(7):e353. PubMed ID: 22825471
[TBL] [Abstract][Full Text] [Related]
10. Nelfinavir inhibits human DDI2 and potentiates cytotoxicity of proteasome inhibitors.
Gu Y; Wang X; Wang Y; Wang Y; Li J; Yu FX
Cell Signal; 2020 Nov; 75():109775. PubMed ID: 32916277
[TBL] [Abstract][Full Text] [Related]
11. Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions.
Alkema NG; Wisman GB; van der Zee AG; van Vugt MA; de Jong S
Drug Resist Updat; 2016 Jan; 24():55-69. PubMed ID: 26830315
[TBL] [Abstract][Full Text] [Related]
12. Nelfinavir and other protease inhibitors in cancer: mechanisms involved in anticancer activity.
Koltai T
F1000Res; 2015; 4():9. PubMed ID: 26097685
[TBL] [Abstract][Full Text] [Related]
13. Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status.
Roering P; Siddiqui A; Heuser VD; Potdar S; Mikkonen P; Oikkonen J; Li Y; Pikkusaari S; Wennerberg K; Hynninen J; Grenman S; Huhtinen K; Auranen A; Carpén O; Kaipio K
Front Oncol; 2022; 12():954430. PubMed ID: 36081565
[TBL] [Abstract][Full Text] [Related]
14. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
15. Nelfinavir induces adipocyte insulin resistance through the induction of oxidative stress: differential protective effect of antioxidant agents.
Ben-Romano R; Rudich A; Etzion S; Potashnik R; Kagan E; Greenbaum U; Bashan N
Antivir Ther; 2006; 11(8):1051-60. PubMed ID: 17302375
[TBL] [Abstract][Full Text] [Related]
16. Antitumorigenic action of nelfinavir: Effects on multiple myeloma and hematologic malignancies (Review).
Allegra A; Innao V; Allegra AG; Pulvirenti N; Pugliese M; Musolino C
Oncol Rep; 2020 Jun; 43(6):1729-1736. PubMed ID: 32236596
[TBL] [Abstract][Full Text] [Related]
17. The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir.
Subeha MR; Telleria CM
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33228205
[TBL] [Abstract][Full Text] [Related]
18. The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia.
Meier-Stephenson V; Riemer J; Narendran A
Onco Targets Ther; 2017; 10():2581-2593. PubMed ID: 28553123
[TBL] [Abstract][Full Text] [Related]
19. Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation.
Brüning A; Rahmeh M; Friese K
Mol Oncol; 2013 Dec; 7(6):1012-8. PubMed ID: 23916134
[TBL] [Abstract][Full Text] [Related]
20. Nelfinavir impairs glycosylation of herpes simplex virus 1 envelope proteins and blocks virus maturation.
Gantt S; Gachelet E; Carlsson J; Barcy S; Casper C; Lagunoff M
Adv Virol; 2015; 2015():687162. PubMed ID: 25709648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
